Evidence map›Paper›PMID 42512317›Full record

ArticleCancers2026

Spatial Architecture of B7-H3-Expressing Cell Subpopulations Predicts Patient Prognosis in Lung Cancer Brain Metastases: A Pilot Study.

Shigeaki Nawa, Mitsugu Fujita, Masasuke Ohno, Shunichiro Kuramitsu, Shota Nohira, Ryuta Saito

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shigeaki NawaDepartment of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Aichi, Japan.
Mitsugu FujitaCenter for Medical Education and Clinical Training, Kindai University Faculty of Medicine, 1-14-1 Miharadai, Minami-ku, Sakai 590-0197, Osaka, Japan.ORCID 0000-0002-0000-9879
Masasuke OhnoDepartment of Neurosurgery, Aichi Cancer Center, 1-1 Shikanodono, Chikusa-ku, Nagoya 464-8681, Aichi, Japan.ORCID 0000-0002-3026-7959
Shunichiro KuramitsuDepartment of Neurosurgery, Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Aichi, Japan.ORCID 0000-0002-8808-3140
Shota NohiraDepartment of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Aichi, Japan.
Ryuta SaitoDepartment of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Aichi, Japan.ORCID 0000-0002-2484-1360

Funding

Ministry of Education, Culture, Sports, Science and Technology 21K09167Ministry of Education, Culture, Sports, Science and Technology 23K15677Ministry of Education, Culture, Sports, Science and Technology 25K12376
6 · The paper itself

Abstract

backgroundThe clinical outcomes of lung cancer brain metastases (LCBMs) are highly variable. Traditional pathology relies on bulk cell densities. These static measures fail to capture the spatial architecture of the tumor immune microenvironment (TIME). B7-H3 (CD276) represents a key immune checkpoint in LCBMs. We investigated whether the spatial orchestration of B7-H3-expressing cell populations is associated with patient prognosis.

methodsMultiplex immunohistochemistry (mIHC) for B7-H3 and Iba1 (a macrophage marker) was performed on surgically resected tissues from 22 patients, with single-cell segmentation and classification in QuPath. We then applied spatial point pattern and spatial autocorrelation analyses to evaluate the relative positioning of single cells, computing spatial interaction metrics, including cross-Moran's I and the cross-K function, within a 35 μm radius. These metrics were correlated with postoperative overall survival (OS), and prognostic thresholds were determined via time-dependent ROC curve analysis.

resultsStandard cell densities generally did not correlate with OS, although B7-H3

conclusionsDecoding the spatial architecture of B7-H3-expressing cell subpopulations provides superior prognostic stratification compared with standard density-based metrics. These localized spatial niches represent potential biomarkers and therapeutic targets for personalized LCBM management.

Indexed as

B7-H3immune microenvironmentlung cancer brain metastasisprognosisspatial analysis

Identifiers

PMID42512317
PMCPMC13406226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.